ImmuCell Corp
NASDAQ:ICCC
ImmuCell Corp
NASDAQ:ICCC
Price:
4.88 USD
-10.89%
Market Closed
Updated:
May 16, 2024
Operating Margin
ImmuCell Corp
ImmuCell Corp
-32.9%
Current
-14%
Average
-8.9%
Industry
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin
=-32.9%
Operating Profit
/
-5.7m
Revenue
17.5m
Operating Margin Across Competitors
| Country | US |
| Market Cap | 37.8m USD |
| Operating Margin |
-33%
|
| Country | US |
| Market Cap | 289.2B USD |
| Operating Margin |
30%
|
| Country | US |
| Market Cap | 171.1B USD |
| Operating Margin |
24%
|
| Country | US |
| Market Cap | 112.7B USD |
| Operating Margin |
39%
|
| Country | US |
| Market Cap | 107.8B USD |
| Operating Margin |
30%
|
| Country | AU |
| Market Cap | 136.7B AUD |
| Operating Margin |
26%
|
| Country | US |
| Market Cap | 83.5B USD |
| Operating Margin |
32%
|
| Country | US |
| Market Cap | 49.4B USD |
| Operating Margin |
-100%
|
| Country | US |
| Market Cap | 43.1B USD |
| Operating Margin |
-33%
|
| Country | US |
| Market Cap | 34.3B USD |
| Operating Margin |
22%
|
| Country | KR |
| Market Cap | 39.6T KRW |
| Operating Margin |
30%
|
Profitability Report
View the profitability report to see the full profitability analysis for ImmuCell Corp.
See Also
Discover More
What is Operating Margin?
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin
=-32.9%
Operating Profit
/
-5.7m
Revenue
17.5m
What is the Operating Margin of ImmuCell Corp?
Based on ImmuCell Corp's most recent financial statements, the company has Operating Margin of -32.9%.
You don't have any saved screeners yet
